NP / PA
O'connor-Wray, Kathy
O'connor-Wray, Kathy was paid $361K by Medicaid between Feb 2018 and Oct 2020, across 43 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoO'CONNOR-WRAY, KATHY
JACKSON, TN 38305
JACKSON, TN 38305
33aNPI1528241999assigned 12/08/2007
33bProvider typeFamily Nurse Practitioner
28Total paid$361K
24GClaims20,179
24DCodes billed43
24AFirst – last monthFeb 2018 – Oct 2020
Compared with peers
Next to other Family Nurse Practitioner providers in Tennessee
Rank by total paid#48 of 687
Median peer was paid$15K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 800 | $18K | |
| 2019 | 9,711 | $177K | |
| 2020 | 9,668 | $166K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 3,575 | 2,965 | $136K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 1,383 | 1,129 | $70K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.2% | 440 | 395 | $26K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.4% | 752 | 708 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.2% | 855 | 677 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.2% | 2,537 | 2,116 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.1% | 934 | 728 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.9% | 1,469 | 1,240 | $14K |
| 96160 | 2.6% | 359 | 319 | $9K | |
| 92552 | 1.9% | 415 | 374 | $7K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 71 | 67 | $5K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 57 | 46 | $5K |
31 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 41 | $3K |
| 81025 | <1% | 554 | $3K | |
| 36416 | <1% | 1,852 | $2K | |
| 80305 | <1% | 425 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 40 | $2K |
| 99173 | <1% | 329 | $2K | |
| 81003 | <1% | 809 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 829 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 76 | $1K |
| 69210 | <1% | 32 | $1K | |
| 3008F | <1% | 344 | $970.00 | |
| 87807 | <1% | 80 | $669.25 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 62 | $590.42 |
| 99201 | <1% | 18 | $549.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 271 | $522.02 |
| 96127 | <1% | 115 | $465.95 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 79 | $425.10 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 240 | $407.79 |
| 1159F | <1% | 94 | $400.00 | |
| 1160F | <1% | 90 | $390.00 | |
| 93000 | <1% | 26 | $356.91 | |
| 87430 | <1% | 65 | $352.18 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 23 | $152.55 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 264 | $108.89 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 12 | $91.02 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 15 | $0.00 |
| 3078F | 0% | 45 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 14 | $0.00 |
| 99000 | 0% | 432 | $0.00 | |
| 3074F | 0% | 37 | $0.00 | |
| 3044F | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.